Patents by Inventor Mary Patricia Knadler

Mary Patricia Knadler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of central nervous system disorders with selective estrogen receptor modulators
    Publication number: 20020013342
    Abstract: The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula 1
    Type: Application
    Filed: May 4, 2000
    Publication date: January 31, 2002
    Inventors: Kelly Renee Bales, Henry Uhlman Bryant, Steven Marc Paul, Mary Patricia Knadler
  • Treatment of central nervous system disorders with selective estrogen receptor modulators
    Patent number: 6077852
    Abstract: The present invention provides a method of treating depression, mood swings, or Alzheimer's disease in a patient in need of such treatment by administering a selective estrogen receptor modulating compound of the formula ##STR1## in which R.sup.1 and R.sup.2 are independently hydroxy and alkoxy of one to four carbon atoms; and R.sup.3 and R.sup.4 are independently methyl or ethyl, or R.sup.3 and R.sup.4, taken together with the nitrogen atom to which they are attached, form a pyrrolidino, methyl-pyrrolidino, dimethylpyrrolidino, piperidino, morpholino, or hexamethyleneimino ring.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: June 20, 2000
    Assignee: Eli Lilly and Company
    Inventors: Kelly Renee Bales, Henry Uhlman Bryant, Steven Marc Paul, Mary Patricia Knadler